Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term in-vivo. Found 70 abstracts

no pagination
Ralff MD, El-Deiry WS. TRAIL pathway targeting therapeutics. Expert Rev Precis Me. 2018 May;3(3):197-204.   PMCID: PMC6366666
Cao Y, Marks JD, Huang Q, Rudnick SI, Xiong CY, Hittelman WN, Wen XX, Marks JW, Cheung LH, Boland K, Li C, Adams GP, Rosenblum MG. Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity. Molecular Cancer Therapeutics. 2012 Jan;11(1):143-53.
Cheng F, Wang HW, Horna P, Wang Z, Shah B, Sahakian E, Woan KV, Villagra A, Pinilla-Ibarz J, Sebti S, Smith M, Tao JG, Sotomayor EM. Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity. Cancer Research. 2012 Sep;72(17):4440-8.   PMCID: No Longer Here
Fu J, Bassi DE, Zhang JR, Li TY, Nicolas E, Klein-Szanto AJ. Transgenic Overexpression of the Proprotein Convertase Furin Enhances Skin Tumor Growth. Neoplasia. 2012 Apr;14(4):271-82.   PMCID: PMC3349254
Hayes DN, Lucas AS, Tanvetyanon T, Krzyzanowska MK, Chung CH, Murphy BA, Gilbert J, Mehra R, Moore DT, Sheikh A, Hoskins J, Hayward MC, Zhao N, O'Connor W, Weck KE, Cohen RB, Cohen EE. Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements. Clinical Cancer Research. 2012 Apr;18(7):2056-65.
Rizzolio F, Lucchetti C, Caligiuri I, Marchesi I, Caputo M, Klein-Szanto A, Bagella L, Castronovo M, Giordano A. Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. Cell death and differentiation. 2012 Jul;19(7):1152-61.   PMCID: PMC3374078
Roscoe F, Xu RH, Sigal LJ. Characterization of Ectromelia Virus Deficient in EVM036, the Homolog of Vaccinia virus F13L, and Its Application for Rapid Generation of Recombinant Viruses. Journal of Virology. 2012 Dec;86(24):13501-7.   PMCID: PMC3503138
Smith ER, Yeasky T, Wei JQ, Miki RA, Cai KQ, Smedberg JL, Yang WL, Xu XX. White spotting variant mouse as an experimental model for ovarian aging and menopausal biology. Menopause-the Journal of the North American Menopause Society. 2012 May;19(5):588-96.   PMCID: PMC3326177
Berger AH, Knudson AG, Pandolfi PP, Venee Wk VP. A continuum model for tumour suppression. Nature. 2011 Aug;476(7359):163-9.   PMCID: PMC3206311
Clapper ML, Hensley HH, Chang WC, Devarajan K, Nguyen MT, Cooper HS. Detection of Colorectal Adenomas Using a Bioactivatable Probe Specific for Matrix Metalloproteinase Activity. Neoplasia. 2011 Aug;13(8):685-91.
del Monte G, Casanova JC, Guadix JA, MacGrogan D, Burch JB, Perez-Pomares JM, de la Pompa JL. Differential Notch Signaling in the Epicardium Is Required for Cardiac Inflow Development and Coronary Vessel Morphogenesis. Circulation research. 2011 Apr;108(7):824-U137.   PMCID: *
Gutierrez A, Grebliunaite R, Feng H, Kozakewich E, Zhu SZ, Guo F, Payne E, Mansour M, Dahlberg SE, Neuberg DS, den Hertog J, Prochownik EV, Testa JR, Harris M, Kanki JP, Look AT. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. Journal of Experimental Medicine. 2011 Aug;208(8):1595-603.   PMCID: PMC3149218
Kennedy AL, Morton JP, Manoharan I, Nelson DM, Jamieson NB, Pawlikowski JS, McBryan T, Doyle B, McKay C, Oien KA, Enders GH, Zhang RG, Sansom OJ, Adams PD. Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis. Mol Cell. 2011 Apr;42(1):36-49.
Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Butnor KJ, Pass HI, Carbone M, Testa JR, Heintz NH, Mossman BT. ERK2 is essential for the growth of human epithelioid malignant mesotheliomas. International journal of cancer. 2011 Sep;129(5):1075-86.   PMCID: PMC3071888 [available 2012/5/12]
Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW, Gray R. Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer. Clinical Cancer Research. 2011 Nov;17(22):7194-203.   PMCID: PMC3570203
Stadanlick JE, Zhang ZQ, Lee SY, Hemann M, Biery M, Carleton MO, Zambetti GP, Anderson SJ, Oravecz T, Wiest DL. Developmental Arrest of T Cells in Rpl22-Deficient Mice Is Dependent upon Multiple p53 Effectors. Journal of Immunology. 2011 Jul;187(2):664-75.   PMCID: PMC3131471
Tsimberidou AM, Lewis N, Reid T, Burris H, Urban P, Tan EY, Anand S, Uehara C, Kurzrock R. Pharmacokinetics and antitumor activity of patupilone combined with midazolam or omeprazole in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 2011 Dec;68(6):1507-16.   PMCID: not NIH funded
Tu ZG, Aird KM, Bitler BG, Nicodemus JP, Beeharry N, Xia B, Yen TJ, Zhang RG. Oncogenic Ras Regulates BRIP1 Expression to Induce Dissociation of BRCA1 from Chromatin, Inhibit DNA Repair, and Promote Senescence. Developmental cell. 2011 Dec;21(6):1077-91.   PMCID: PMC3241855
Bernardo GM, Lozada KL, Miedler JD, Harburg G, Hewitt SC, Mosley JD, Godwin AK, Korach KS, Visvader JE, Kaestner KH, Abdul-Karim FW, Montano MM, Keri RA. FOXA1 is an essential determinant of ER alpha expression and mammary ductal morphogenesis. Development. 2010 Jun;137(12):2045-54.   PMCID: PMC2875844
Bruno T, Desantis A, Bossi G, Di Agostino S, Sorino C, De Nicola F, Iezzi S, Franchitto A, Benassi B, Galanti S, La Rosa F, Floridi A, Bellacosa A, Passananti C, Blandino G, Fanciulli M. Che-1 Promotes Tumor Cell Survival by Sustaining Mutant p53 Transcription and Inhibiting DNA Damage Response Activation. Cancer cell. 2010 Aug;18(2):122-34.   PMCID: not NIH funded
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term in-vivo

in-vivo cancer receptor expression breast-cancer gene-expression growth mice retinoic acid cellular senescence inhibition pathway gene epithelial-cells survival prevalence myeloma cells proliferation gata-3 heart challenge signal-regulated kinases cells epdcs malignant-transformation activation neu-overexpressing metastatic breast vasculogenesis 1989 audhary vk-nature-v339-p394 efficacy hematopoietic stem-cells genetic dissection cells multiple intestinal neoplasia p73 induces apoptosis gene family cell differentiation chromosome mutations pten expression her2 animal toxicity progression nuclear pten antitumor-activity adults viral disease phase-ii Pharmacokinetics checkpoint 2002 llo sp-biol chem-v383-p69 akt apoptosis tumorigenesis mitogen-activated protein kinases matrix-metalloproteinase breaks cytotoxic t-lymphocytes progenitor survival dna-damage acute promyelocytic leukemia b-myb transgenic zebrafish kinase peptide mediated apoptosis solid tumors death receptor dr4 c-myc notch1 cell-cycle arrest apoptosis-inducing ligand Omeprazole causative braf mutations signaling pathways basal-like subtype growth arrest agent 1995 ng cx-v82-p675 genomic instability tumor angiogenesis map kinase progesterone-receptor dendritic cells s-phase braf(v600e) mutation wild-type polymerase chain-reaction pleural mesothelioma epothilones 1991 ing ms-british journal of clinical pharmacology-v31-p166 estrogen-receptor-alpha human head tic10 mouse Midazolam Ovarian follicles Menopause-Germ cells-c-kit-Wv mice-Mouse model sex steroids monoclonal-antibody 2) kinase kinase-1 coronary vessel development epicardium-Notch-Wilms tumor-1 inhibitor golgi network pp2a 1000 bchy a-clin canc res-v16-p5351 mouse skin cancer-cells signaling recombinant immunotoxin formation trail tcr signals ptc 2 inhibitor growth-factor chemotherapy induced apoptosis fas ligand Drug interaction interacts cytochrome-c release solid cancer risk pten p53 tumor suppression pre-tcr doxorubicin microtubule-stabilizing agents glucose-homeostasis perimenopause vectors tumors small-molecule onc201 proepicardium Phase 1 meiotic cells cancer-therapy cell-mediated resistance asbestos Pin1 pRb phosphorylation-CDK-cell cycle control mesothelioma cd8(+) t-cells gene expression conditional loss glycogen-synthase kinase-3 infection heterochromatin damage response
Last updated on Thursday, June 04, 2020